Skip to main content
Kidney International Reports logoLink to Kidney International Reports
letter
. 2021 Oct 30;7(1):127–128. doi: 10.1016/j.ekir.2021.10.020

Concurrent Antiglomerular Basement Membrane Nephritis and Antineutrophil Cytoplasmic Autoantibody–Mediated Glomerulonephritis After Second Dose of SARS-CoV-2 mRNA Vaccination

Rajib K Gupta 1,, Brigid K Ellis 2
PMCID: PMC8556066  PMID: 34746518

To the Editor:

Recently, a few cases have been reported of patients developing either antiglomerular basement membrane nephritis or antineutrophil cytoplasmic autoantibody–mediated nephritis after vaccinations with either the Pfizer-BioNTech or Moderna SARS-CoV-2 mRNA vaccine.1,2 We describe a rare case of concurrent antiglomerular basement membrane and antineutrophil cytoplasmic autoantibody–mediated glomerulonephritis after COVID-19 vaccination with the second dose of the Moderna vaccine.

A 23-year-old Hispanic male with a history of fragile X syndrome and interstitial lung disease of unclear etiology presented with 3 months of weakness, fatigue, and weight loss that started approximately 2 weeks after receiving his second dose of the Moderna vaccine. On presentation, he had a creatinine level of 14 mg/dl, a hemoglobin level of 7.4, and a urinalysis result revealing large blood (62 red blood cells per high-power field) and a spot urine protein-creatinine ratio of 1.5 g/g. Serologic workup was significant for positive c-antineutrophil cytoplasmic autoantibody at 1:5240, anti-MPO IgG at 249 arbitrary units/ml (anti-PR3 WNL), positive antiglomerular basement membrane antibody, and antinuclear antibody titer at 1:80 with a speckled pattern and normal complements. He had no known previous renal disease and had a creatinine level of 0.7 mg/dl in 2017.

The kidney biopsy result revealed a diffuse crescentic glomerulonephritis picture with approximately 80% to 90% of the glomeruli having crescents and associated with variable extent of ruptured capillary tufts, karyorrhectic nuclear debris, and disruption of Bowman’s capsule (Figure 1); a rare periglomerular multinucleate giant cell was also noted, a feature often reported in concurrent cases.3 The interstitium had a mixed inflammatory infiltrate, patchy acute tubular injury, and few red cell casts. Immunofluorescence study results revealed strong linear staining of glomeruli for IgG, kappa, and lambda.

Figure 1.

Figure 1

(a) Strong linear glomerular basement membrane staining on IgG immunofluorescence, ×400. (b) Pure cellular circumferential crescent with a ruptured glomerulus at its center, Jones silver ×400. (c) Two glomeruli, each having contracted ruptured capillary tufts and surrounded by organizing crescents, associated with fibrinoid necrosis (left glomerulus), Bowman’s capsule rupture, and periglomerular inflammation, PAS ×200. (d) A single glomerulus with near-complete destruction, Bowman capsule rupture, and a periglomerular multinucleate giant cell, PAS ×400. PAS, periodic acid-Schiff.

This is the first case of a concurrent antineutrophil cytoplasmic autoantibody and antiglomerular basement membrane glomerulonephritis after COVID-19 vaccination. A heightened awareness should be maintained for such unfortunate kidney complications, particularly in patients with pre-existing diseases or known immune dysregulation.4

Disclosure

All the authors declared no competing interests.

References

  • 1.Sacker A., Kung V., Andean A. Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV2 mRNA vaccination. Kidney Int. 2021;100:471–472. doi: 10.1016/j.kint.2021.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sekar A., Campbell R., Tabbara J., Rastogi P. ANCA glomerulonephritis post Moderna COVID-19 vaccination. Kidney Int. 2021;100:473–474. doi: 10.1016/j.kint.2021.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rutgers A., Slot M., van Paassen P., van Breda Vriesman P., Heeringa P., Tervaert J.W. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase -ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253–262. doi: 10.1053/j.ajkd.2005.05.003. [DOI] [PubMed] [Google Scholar]
  • 4.Yu K.H., Palmer N., Fox K., et al. The phenotypical implications of immune dysregulation in fragile X syndrome. Eur J Neurol. 2020;27:590–593. doi: 10.1111/ene.14146. [DOI] [PubMed] [Google Scholar]

Articles from Kidney International Reports are provided here courtesy of Elsevier

RESOURCES